Cost-effectiveness of sustained-release morphine for refractory breathlessness in COPD: A randomized clinical trial

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number106330
Number of pages9
JournalRespiratory Medicine
Volume179
DOIs
Publication statusPublished - Apr 2021

Keywords

  • COPD
  • Morphine
  • Breathlessness
  • Cost-effectiveness
  • OBSTRUCTIVE PULMONARY-DISEASE
  • QUALITY-OF-LIFE
  • HEALTH-CARE
  • DYSPNEA
  • PREVALENCE
  • OPIOIDS
  • DISABILITY
  • SYMPTOMS
  • BURDEN
  • CAT

Cite this